Merck (MRK) Income from Non-Controlling Interests (2009 - 2026)
Merck's Income from Non-Controlling Interests came in at -$2 million for Q2 2026, compared with $1 million a year earlier.
Powered by 
Analysis
Merck (MRK) Income from Non-Controlling Interests (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Merck reported Income from Non-Controlling Interests of -$4 million; for FY2025, it was $9 million, down 43.8% from FY2024.
- Income from Non-Controlling Interests carries a five-year compound annual growth rate of -9.7% (FY2020 to FY2025).
- Going back by year, Income from Non-Controlling Interests was $16 million in FY2024 (+33.3%), $12 million in FY2023 (+71.4%) and $7 million in FY2022.
- The five-year range for quarterly Income from Non-Controlling Interests is -$3 million (Q1 2026) to $6 million (Q1 2025).
- Year-over-year, Income from Non-Controlling Interests increased in 1 of the last four quarters, with an average decline of 33.3%.
- Business Quant data shows MRK's Income from Non-Controlling Interests at -$3 million (Q1 2026), -$1 million (Q4 2025) and $2 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | - |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 3.00 Mn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | -2.00 Mn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | -7.00 Mn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 1.00 Mn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | - |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 10.00 Mn |
| 10 | Vertex Pharmaceuticals | 126.70 Bn | 98.70 Bn | 2.84 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.00 Mn |
| Mar 31, 2026 | -3.00 Mn |
| Dec 31, 2025 | -1.00 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | 6.00 Mn |
| Dec 31, 2024 | 1.00 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | 6.00 Mn |
| Mar 31, 2024 | 5.00 Mn |
| Sep 30, 2023 | 5.00 Mn |
| Jun 30, 2023 | 3.00 Mn |
| Mar 31, 2023 | 4.00 Mn |
| Dec 31, 2022 | 1.00 Mn |
| Sep 30, 2022 | 5.00 Mn |
| Mar 31, 2021 | 7.00 Mn |
| Dec 31, 2020 | 3.00 Mn |
| Sep 30, 2020 | 4.00 Mn |
| Jun 30, 2020 | 8.00 Mn |
| Dec 31, 2019 | 7.00 Mn |
API Access
Merck Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=MRK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "MRK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=MRK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();